Entero Healthcare Solutions Limited — PPTs, 25-05-2026: Investor Presentation

Here's a concise summary for Entero Healthcare Solutions Limited, tailored for retail investors:

**1. Business Performance:** Entero Healthcare reported robust FY26 revenue up 29.3% YoY to INR 6,591.2 Cr; Q4 surged 42.6%. EBITDA margin notably improved to 4.0% for FY26 (from 3.4%), reaching 4.5% in Q4. Organic growth outpaced the Indian pharma market by 1.6x.

**2. Growth Drivers or Strategy:** Consolidating India's fragmented healthcare supply chain via scale & tech is key. MedTech expansion is critical, projected to contribute >INR 1,000 Cr in FY27, diversifying market reach.

**3. Recent Developments:** FY26 saw seven acquisitions, including three in MedTech. Entero achieved positive operating cashflow of INR 96.2 Cr for FY26, with Q4 alone generating INR 104.6 Cr, driven by improved working capital.

**4. Key Financial Metrics:** FY26 EBITDA: INR 266.0 Cr. Profit After Tax (PAT) for owners: INR 115.0 Cr.

**5. Management Commentary / Outlook:** Management forecasts FY27 revenue growth of 23.0% (excl. new acquisitions), 5.0% EBITDA margin, and 50% operating cashflow to EBITDA conversion, confident in market consolidation.